Overview
Changlong Xu practices practicing medicine in Nanning, China.
Their clinical expertise encompasses Mosaicism, Cystic Fibrosis, Infertility, and Alpha Thalassemia.
They are actively involved in clinical research, co-authoring 33 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Changlong Xu
Is Changlong Xu a top-rated expert for Mosaicism?
MediFind is an objective health platform that identifies experts based on real-world data. Changlong Xu is classified as an Experienced expert for Mosaicism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Changlong Xu participate in research or clinical trials?
Yes. Changlong Xu has published 33 articles and abstracts on conditions like Mosaicism. You can view a list of Changlong Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alpha ThalassemiaXu isExperienced. Learn about Alpha Thalassemia.
- Cystic FibrosisXu isExperienced. Learn about Cystic Fibrosis.
- InfertilityXu isExperienced. Learn about Infertility.
- MosaicismXu isExperienced. Learn about Mosaicism.
- Secondary PeritonitisXu isExperienced. Learn about Secondary Peritonitis.